Optometrists in Baker, LA Accepting Medicare
5 Optometrists found. Showing 1 - 5
 Dr. Shondra Moore, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 12880 Plank Rd, Baker, LA 70714 Phone: 225-775-3994 Fax: 225-775-2190 |
 Baker Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 12880 Plank Rd, Baker, LA 70714 Phone: 225-775-3994 Fax: 225-775-2190 |
Ashley's Optical, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 13131 Plank Rd, Baker, LA 70714 Phone: 225-775-9406 Fax: 225-775-0258 |
Dr. Yvonne Major, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 13930 Plank Rd, Baker, LA 70714 Phone: 225-775-9665 Fax: 225-775-9667 |
 Dr. Lannie Michael Calhoun, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 13131 Plank Rd, Baker, LA 70714 Phone: 225-775-9406 Fax: 225-775-0258 |
News Archive
For safety, NHLBI changes intensive blood sugar treatment strategy in trial of diabetes and cardiovascular disease
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped one treatment within a large, ongoing North American clinical trial of diabetes and cardiovascular disease 18 months early due to safety concerns after review of available data, although the study will continue.
Established human embryonic cell lines vary from newly derived stem cell lines
Established human embryonic cell lines, including those approved for federal research funding under former President George W. Bush, are different than newly derived human embryonic stem cell lines, according to a study by UCLA stem cell researchers.
HOOKVAC consortium awarded grant to develop, test vaccine for human hookworm
The HOOKVAC consortium, led by the Academic Medical Center at the University of Amsterdam, today announced it has been awarded a grant of six million Euros from the European Commission FP7 programme to expand the Sabin Vaccine Institute Product Development Partnership's (Sabin PDP) work to develop and test a vaccine for human hookworm, a disease that infects 600-700 million of the world's poorest people.
Study: Nasal therapy is more effective than commonly used IgG antibodies at neutralizing COVID-19 virus
A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc.
› Verified 3 days ago
Optometrists
Speech-Language Pathologists
Physical Therapists
Chiropractors
Occupational Therapists